reference/33416340

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33416340

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	75
issn	0161-5505
issueIdentifier	5
pageRange	768-75
publicationName	Journal of nuclear medicine : official publication, Society of Nuclear Medicine
startingPage	768
bibliographicCitation	Ramos-Suzarte M, Rodríguez N, Oliva JP, Iznaga-Escobar N, Perera A, Morales A, Gonzalez N, Cordero M, Torres L, Pimentel G, Borrón M, González J, Torres O, Rodríguez T, Pérez R. 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy. J Nucl Med. 1999 May;40(5):768–75. PMID: 10319748.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f329b6d82a5f7ae7ecd92d1352868962 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a06e169713d3a4b5cb983bf1a5fb74f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f079c5ad549386e0a7c912cd31d5d28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd7d580c193f1b762044403479b00649 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9592ce2ce3da95c7c22238ae42c59740 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c013afda18e8dc7e57f1e054eff55992 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_167b8d23977eb026d70e4a32823d24dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c460f1b4b4d2c2210bacd4080577adfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c55410cdfc0d1ee6ebac40a060186dc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d10f79bcc29e7da49de028a27298f27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5bd5e2deb896673c6eef5d1ff856cec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a80a4a192ff18ce5a16ea35911ce6f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63a17e22a31f8a2f80a19313727a2453 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4da0acd62dac2d94843d18f38df0360e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a96f6f56926ec6ad2a4fedb31846049
date	199905
identifier	https://pubmed.ncbi.nlm.nih.gov/10319748
isPartOf	https://portal.issn.org/resource/ISSN/0161-5505 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5045
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy
discusses	http://id.nlm.nih.gov/mesh/M0021100 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0028704
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009375Q000000981 http://id.nlm.nih.gov/mesh/D013670 http://id.nlm.nih.gov/mesh/D066246Q000276 http://id.nlm.nih.gov/mesh/D016719
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015899 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D019275 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D007091 http://id.nlm.nih.gov/mesh/D012680 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1afa7fd0ba0dd4b1291127bcaf1842d3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_966b69495aff24dd4bc4208192414e49 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390

Total number of triples: 55.